GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 96 8. Provide details of any corrective actions taken or underway to address significant risks / concerns arising from the assessments at Question 9 above. Since your company is compliant, there was no corrective action suggested by any auditing / inspecting authority / official. Leadership Indicators 1. Is the premise/office of the entity accessible to differently abled visitors, as per the requirements of the Rights of Persons with Disabilities Act, 2016? Yes, your company’s corporate office in Worli, Mumbai is accessible to differently abled visitors. 2. Details on assessment of value chain partners: For matters related to sexual harassment, discrimination, labour, wages, etc.: As part of your company’s onboarding process, for all third-party vendors, suppliers, and contract manufacturers, various risks including labour rights and health and safety are assessed. The suppliers, vendors, and contract manufacturers are evaluated on their existing policies and procedures for dealing with issues relating to sexual harassment, discrimination, child labour, forced labour, and fair wages. In the previous FY 2021-22, no physical audits were carried out due to the pandemic. 3.6. Principle 6: Businesses should respect and make efforts to protect and restore the environment We consider sustainability in our ways of doing business and believe that collectively we can make a difference. We continuously monitor and evaluate our operations to improve their efficiency, deploy impactful waste management practices at our units and offices, and thereby reduce the impact we create on the environment. We have successfully integrated the Environment, Health, Safety and Sustainability (EHSS) strategy across our value chain. This has enabled us to comply with necessary applicable environmental laws and mandates during the manufacturing and commercial activities. Additionally, Good Manufacturing Practices are strictly followed during the manufacturing of the products. During this year, we have considered the usage of renewable energy for the conversion of boilers to biomass and photovoltaic solar power systems in the manufacturing units to reduce environmental impacts. Globally, GSK has set two ambitious goals: a net-zero impact on carbon and a net positive impact on nature by 2030. We strongly believe in our path toward the goals set forth and we reaffirm our aspirations to integrate sustainability into the core of our business and manufacture products. For our vaccines business, your company migrated from passive transportation to active transportation for key locations, making the use of thermocol boxes and coolants redundant. Instead, vaccines are now transported regularly and stored in coolers with the Clearing and Forwarding Agents (CFAs) and stockists. This has led to reduction in your company’s carbon footprint. Essential Indicators 1. Details of total energy consumption (in Joules or multiples) and energy intensity, in the following format: (Note: below data under (A), (B) is for Nashik and Corporate Office) Parameter FY 2021-22 FY 2020-21 Total electricity consumption (A) 1,58,15,356 kWh (56,935.28 gigajoules) 1,56,97,567 kWh (56,511.24 gigajoules) Energy consumption through other sources (B) 200 kWh (0.72 gigajoules) 120 kWh (0.43 gigajoules) Total energy consumption (A+B) 1,58,15,556 kWh (56,936 gigajoules) 1,56,97,687 kWh (56,511.67 gigajoules) 2. Does the entity have any sites / facilities identified as designated consumers (DCs) under the Performance, Achieve and Trade (PAT) Scheme of the Government of India? The entity does not have any sites/ facilities identified as designated consumers (DCs) under the Performance, Achieve and Trade (PAT) Scheme of the Government of India Business Responsibility and Sustainability Report